However, it appears likely that our data also reflect unequal kinetics of the changes of coagulation factors and natural anticoagulants during the course of liver cirrhosis, as for example the activity of protein S appears to be largely unaffected even in patients with end stage liver disease (Fig 1). Here, PROS1 is linked to cirrhosis of liver.